drugset / Trial / NCT05222646

Metoclopramide Versus Hyoscine Butylbromide in Shortening Duration of First Stage of Labour

NCT05222646

Phase 1 Unknown 150 enrolled Uwakwe Emmanuel Chijioke
RandomizedParallel-groupDouble-blindPrevention

Summary

BACKGROUND Prolonged labour can lead to increased maternal and neonatal mortality and morbidity. The risk for complications of prolonged labour is more in poor resource settings. Active management of labour has been shown to decrease the occurrence of prolonged labour. Administering antispasmodics during labour could also lead to faster and more effective dilatation of the cervix. As the evidence to support this is still largely anecdotal around the world, there is a need to conduct clinical trials so as to obtain a valid answer.

Timeline

Start
2022-01-03
Primary completion
2022-08-03
Completion
2022-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 10 mg Intramuscular

Indications

No indication recorded.